- Q1 142
- Q2 122
- Q3 93
- Q4 21
Academician
SERCAN AKSOY
PROFESÖR
HACETTEPE ÜNİVERSİTESİ KANSER ENSTİTÜSÜ KLİNİK ONKOLOJİ ANABİLİM DALI
Research topics OpenAlex
- HER2/EGFR in Cancer Research25
- Advanced Breast Cancer Therapies22
- Cancer Treatment and Pharmacology21
- Gastric Cancer Management and Outcomes19
- Breast Cancer Treatment Studies18
- Cancer Immunotherapy and Biomarkers17
- Head and Neck Cancer Studies16
- Radiopharmaceutical Chemistry and Applications12
- Colorectal Cancer Treatments and Studies12
- Chemotherapy-induced cardiotoxicity and mitigation10
- Inflammatory Biomarkers in Disease Prognosis9
- Breast Lesions and Carcinomas9
- Ana Dal Sağlık Bilimleri Temel Alanı
- Yan Dal Tıbbi Onkoloji (İç Hastalıkları)
Academic summary
YÖKSİS and OpenAlex counted separately.
Articles
535
YÖKSİS535
OpenAlex0
Projects
42
Books
14
Proceedings
609
Citation impact
OpenAlex YÖKSİS articles matched in OpenAlex: 145
h-index
26
Percentile in Türkiye: 99
#26 of 1,074 at their university by h-index
- i10-index
- 75
- Total citations
- 2,907 Top 1.0% in Türkiye
- Per article
- 20.0
- FWCI
- 1.42 1.00 = world average
- World top 1%
- 2
- World top 10%
- 25
Most cited articles
h-index and citations are computed from the citation counts of this academic’s YÖKSİS articles matched in OpenAlex (not Google Scholar, WoS or Scopus). Unmatched articles are not included.
Field ranking
YÖKSİS ?-
Main field Sağlık Bilimleri Temel AlanıPoints rank #8/ 43,834 top 0.0%Score 346.95 journal 340.2 · OA add 6.75
- Article rank10/43,834
- Scopus rank10/43,834
- WoS rank10/43,834
- YÖKSİS535
- Scopus376
- WoS383
-
Side field Tıbbi Onkoloji (İç Hastalıkları)Points rank #1/ 318 top 0.3%Score 346.95 journal 340.2 · OA add 6.75
- Article rank2/318
- Scopus rank2/318
- WoS rank2/318
- YÖKSİS535
- Scopus376
- WoS383
Index quartiles
?- Q1 90
- Q2 58
- Q3 122
- Q4 116
34 articles
- Top 1% 2
- Top 10% 35
- Avg 65.4%
- n 209
Other counts
Scopus (SJR)
- Excluding abstracts 372 Q1 139 Q2 122 Q3 93 Q4 20
- Best Q 376 Q1 142 Q2 121 Q3 92 Q4 21
- YÖKSİS rows 789
WoS (JCR)
- Excluding abstracts 378 Q1 87 Q2 58 Q3 122 Q4 115
- Best Q 382 Q1 90 Q2 57 Q3 121 Q4 114
- YÖKSİS rows 793
TR Index
- Excluding abstracts 33 articles
- YÖKSİS rows 55 articles
Articles
Articles with YÖKSİS and OpenAlex source split; narrow by quartile or TR Index.
Journals with publications
145 journals
- Journal of B.U.ON. 39
- Medical Oncology 31
- Asian Pacific Journal of Cancer Prevention 26
- Breast 12
- Current Medical Research and Opinion 12
- UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi 12
- 2241-6293 9
- Future Oncology 9
- Supportive Care in Cancer 8
- Annals of Oncology 7
- International Journal of Cancer 7
- Journal of Clinical Medicine 7
- Southern Medical Journal 7
- BMC Cancer 6
- Journal of Clinical Oncology 6
- Turkish Journal of Medical Sciences 6
- Breast Journal 5
- Leukemia and Lymphoma 5
- Acta Oncologica 4
- BMJ Supportive and Palliative Care 4
- Cancer Research 4
- Expert Review of Anticancer Therapy 4
- Hepato-Gastroenterology 4
- Indian Journal of Cancer 4
- World Journal of Gastroenterology 4
- American Journal of Hematology 3
- Cancer Chemotherapy and Pharmacology 3
- Cancers 3
- European Archives of Oto-Rhino-Laryngology 3
- Immunotherapy 3
- International Journal of Clinical Oncology 3
- Journal of Neuro-Oncology 3
- Journal of Oncological Science 3
- Journal of Oncology Pharmacy Practice 3
- Medical Hypotheses 3
- Microchemical Journal 3
- Nature Communications 3
- 0141-9854 2
- 2168-8184 2
- Acta Medica Mediterranea (discontinued) 2
- Annals of Pharmacotherapy 2
- Biomarkers in Medicine 2
- Cancer Treatment Reviews 2
- Chemotherapy 2
- Frontiers in Oncology 2
- Journal of Cancer Research and Therapeutics 2
- Journal of Chemotherapy 2
- Journal of Endocrinological Investigation 2
- Journal of the National Medical Association 2
- Lung Cancer 2
- Medicine (United States) 2
- Molecular and Clinical Oncology 2
- Neoplasma 2
- New England Journal of Medicine 2
- Pain Medicine (United States) 2
- Prostate 2
- Rheumatology International 2
- Strahlentherapie und Onkologie 2
- Tumori 2
- Turkish Journal of Cancer 2
- Urologic Oncology: Seminars and Original Investigations 2
- 0304-596X 1
- 1070625 1
- 1198-0052 1
- 1300-1744 1
- 2020-0024 1
- 2021-0031 1
- 2021-0303 1
- 2147-9488 1
- 2148-2357 1
- 2148-7758 1
- 2149-5254 1
- 2165-7386 1
- 2465-9652 1
- 2553-6594 1
- 2641-6043 1
- 2667-7849 1
- 2717-7505 1
- 284186x 1
- 3447-2040 1
Showing the first 80 journals (145 in total).
Article list
- 2026 6 Minute pegboard and ring test performance of patients with breast cancer compared to healthy controls: A cross-sectional study YÖKSİS SJR Q2 JCR Q3 OpenAlex 29.1%
- 2026 Real‐world effectiveness and safety of sacituzumab govitecan in patients with metastatic or unresectable locally advanced triple‐negative breast cancer: A multicenter study by the Turkish Oncology Group YÖKSİS SJR Q1 JCR Q2 OpenAlex 68.3%
- 2025 Impact of trastuzumab emtansine (T-DM1) on spleen volume in patients with HER2-positive metastatic breast cancer YÖKSİS SJR Q2 JCR Q3
- 2025 Prognostic Nutritional Index and a Blood-Based Prognostic Tool in Prostate Cancer Treated with Abiraterone, Enzalutamide or Cabazitaxel YÖKSİS SJR Q2 JCR Q1
- 2025 Clinical Characteristics and Management of Patients Admitted to the Supportive Care Clinic and Predisposing Factors of Unplanned Hospital Readmission: Single-Center Experience YÖKSİS SJR Q2 JCR Q1
- 2025 Health-related quality of life and psychosocial outcomes in long-term survivors treated with immune checkpoint inhibitors: a nationwide multicenter study YÖKSİS SJR Q1 JCR Q1 OpenAlex 79.2%
- 2025 Real-world effectiveness and safety of sacituzumab govitecan in patients with metastatic or unresectable locally advanced triple-negative breast cancer: A multicenter study by the Turkish Oncology Group YÖKSİS SJR Q1 JCR Q2
- 2025 Talazoparib in patients with BRCA mutant metastatic breast or ovarian carcinoma: results of early access program YÖKSİS SJR Q2 JCR Q2
- 2025 Serum Albumin–Creatinine Ratio and Anthracycline Cardiotoxicity in Patients with Cancer YÖKSİS SJR Q2 JCR Q1
- 2025 Efficacy of first-line CDK 4-6 inhibitors in premenopausal patients with metastatic breast cancer and the effect of dose reduction due to treatment-related neutropenia on efficacy: a Turkish Oncology Group (TOG) study YÖKSİS SJR Q3 JCR Q3 OpenAlex 87.7%
- 2025 Prognostic significance of ductal carcinoma in situ coexisting with invasive ductal carcinoma: Biological behavior, immune response and survival outcomes YÖKSİS SJR Q3 JCR Q4
- 2025 The association between blood sodium levels and survival in patients treated with immune checkpoint inhibitors YÖKSİS SJR Q1 JCR Q1
- 2025 Prognostic value of serum albumin-creatinine ratio as a biomarker in patients treated with immune checkpoint inhibitors YÖKSİS SJR Q3 JCR Q3
- 2025 Oral selective estrogen receptor degraders (SERDs) in hormone receptor-positive HER2-negative metastatic breast cancer after progression with CDK4/6 inhibitors YÖKSİS SJR Q2 JCR Q3
- 2025 Real-world evidence of ribociclib-induced hepatotoxicity in patients with breast cancer: a multi-center experience YÖKSİS SJR Q2 JCR Q2
- 2025 Albumin-myosteatosis gauge as a prognostic biomarker in patients treated with immune checkpoint inhibitors YÖKSİS SJR Q3 JCR Q3
- 2025 The association between HALP score and survival in patients treated with immune checkpoint inhibitors YÖKSİS SJR Q2 JCR Q3
- 2025 Real-world treatment patterns and survival outcomes in metastatic head and neck adenoid cystic carcinoma YÖKSİS SJR Q2 JCR Q2 OpenAlex top 10% OpenAlex 94.5%
- 2025 Induction or Adjuvant Chemotherapy in Patients with Locally Advanced Nasopharyngeal Cancer Receiving Chemoradiotherapy? A Turkish Oncology Group Study YÖKSİS SJR Q2 JCR Q1 OpenAlex 14.7%
- 2025 Ribociclib-induced autoimmune-like hepatitis: a case report YÖKSİS SJR Q3 JCR Q3 OpenAlex 79.6%